Future Pricing and Reimbursement strategies from ABPI, IMS Health, Baxalta, Shire
SMi Group's 22nd annual European Pharmaceutical Market Access, Pricing and Reimbursement conference will be running at Holiday Inn, Kensington Forum in London from 10-11 October 2016.
- (1888PressRelease) June 30, 2016 - Recently in the news: "On June 24, 2016, there was a historic decision - the United Kingdom voted to leave the European Union... What will be the impact on the pharma and biotech industry?
First, the global big pharmaceutical companies that have major exposure to Europe will be impacted significantly, as well as the pricing and reimbursement environment...
However, big pharmaceutical companies based in UK, the depreciating domestic currency could boost earnings.... Another challenge for the industry would be a different drug approval for the United Kingdom". (Source: Market Realist, Jun 27, 2016)
SMi's 22nd annual European Pharmaceutical Market Access, Pricing and Reimbursement will gather industry experts discussing future P&R strategies in this historical moment.
David Watson, Director of Pricing and PPRS, Association of British Pharmaceutical Industry will be presenting on: The UK pricing and reimbursement landscape. Accelerated Access Review (AAR), current pricing strategies and market access arrangements, the future of UK pricing will be discussed.
Alexander Natz, Secretary General, EUCOPE will discuss current challenges in European market access, pricing and reimbursement.
Smita Sealey, UK Engagement Manager, Market Access, IMS Health will be presenting on: New Cancer Drugs Fund (CDF) UK 2016 - what to expect next.
This year's packed programme includes unique presentations, case studies and panel discussions delivered by leading experts from Shire International, IGES, Baxalta, Evidera, IGES, Cell & Gene Therapy Catapult, Office of Health Economics, Lundbeck, Novartis, Quintiles, Alcon and many more.
For further information about the event please visit: www.pharmaceuticalpricing.co.uk/1888
Conference will feature two exclusive post-conference workshops:
A: HTA and reimbursement decisions for innovative medicines
Workshop Leader: Patrick Mollon, Former Director Global Health Economics & Outcomes Research, Novartis; HEOR Director, PMHE2020
B: Managing the global to local challenge
Workshop Leader: Janice Haigh, Practice Leader, Quintiles
Attendees are advised to register before 30th June to save £400.
For media enquiries please contact Anna Serazetdinova on +44 20 7827 6180 or aserazetdinova ( @ ) smi-online dot co dot uk
For delegate enquiries contact Fateja Begum +44 (0) 20 7827 6184 or email fbegum ( @ ) smi-online dot co dot uk
For sponsorship opportunities contact Alia Malick on +44 (0) 20 7827 6168 or email: amalick ( @ ) smi-online dot co dot uk
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam